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Abstract
Conventional neurostimulation systems for preclinical research can be bulky and invasive due to the need for
batteries or wired interfaces. Emerging as a new neural interface technique, ultrasound-powered piezoelectric
neural stimulators work by converting ultrasound energy to electrical charge for neural stimulation. In addition to
the benefits of wireless powering and miniaturization leading to less traumatic surgery, piezoelectric neural
stimulators can also exhibit prolonged operational lifetimes for a long-term stable neural interface, and show
promise for clinical translation. As one of first steps to demonstrate the value of ultrasound-powered piezoelectric
neural interface, Li et al. developed a piezoelectric stimulator to activate spinal cord neural circuits for locomotion
restoration in a rat model with spinal cord injury (SCI) and compared its efficacy with conventional electrical
stimulation (ES). From the point of view of materials science, neural engineering and microelectronics, we provide
our commentary on the article, highlighting its importance and discussing the issues that remain to be addressed
in future studies in the emerging field of ultrasound powered piezoelectric neurostimulation devices.
Keywords: Piezoelectric neural stimulator, Spinal cord injury, Ultrasound, Wireless power, Implantable electronics,
Neuromodulation

Background
Most active electronic medical implants today utilize
onboard batteries as their power source. The necessity
for periodic battery replacement not only constrains the
lifetime of the medical implants, but also requires further
surgeries that result in additional trauma for patients. For
example, a non-rechargeable battery used for a deep brain
stimulator was reported to have a lifetime of 4 to 5 years,
according to an investigation with 192 patients (Helmers
et al. 2018). Consequently, many wireless power transfer
techniques have emerged as alternative approaches for providing energy for device operation, including inductive
coupling, ultrasound, radio frequency and heat (Taalla
et al. 2019). The use of ultrasound to power medical
devices has benefits of volume reduction of implants (down
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to mm dimensions) (Charthad et al. 2015), operation
across longer depths of tissue (~ 10 cm) (Charthad et al.
2018), and moderate power transfer efficiency (~ 40%, depending on working distance) (Ozeri et al. 2010). Wireless
powering technologies for clinical applications are mature
and utilized in many marketed devices, but the issue of
providing long lasting power for preclinical devices is of
particular importance because batteries do not scale as
readily as electronics, and studies utilizing small animal
models have significant constraints on device size and
mass. In addition to the work by Li et al. (Li et al. 2020),
here we also examine another recently developed neural
stimulation system powered by ultrasound, a smaller
millimeter-scale device used to interface the sciatic nerve
with bidirectional communication capability (Piech et al.
2020). These two examples allow us to compare some of
the design tradeoffs of different implementations of this
emerging technology.
Traumatic spinal cord injury (tSCI), mostly caused by
accidents, severs the signal flow between brain and body
systems, resulting in as-yet irreversible loss of functions,
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such as paralysis. Globally, it is estimated that more than
27 million patients are living with long-term disability
due to SCI, while in North America alone there are 12,
500 new cases of SCI each year (Hachem et al. 2017;
Bradbury and Burnside 2019). Etiologically, tSCI is the
most common form and accounts for more than 90% of
SCI cases (James and Theadom 2019). In spite of the
recent progress in neuroscience and biomedical engineering, there has been no effective therapy to regenerate
adult central nervous system axons and repair the spinal
cord pathways after severe SCI (de Cassia Sampaio et al.,
2016). Epidural spinal cord stimulation shows promise to
promote and restore voluntary movement, after chronic
neurologically complete SCI (Darrow et al. 2019).
In the article published in Bioelectronic Medicine, Li
et al. proposed an ultrasound-driven barium titanate
(BaTiO3) piezoelectric stimulator for restoration of involuntary locomotion in rats with SCI by means of epidural
spinal cord stimulation. Figure 1 shows the working
principle of the ultrasound-driven piezoelectric stimulator
interfacing the spinal cord for the restoration of involuntary locomotion. Similar to conventional electrical stimulation (ES), the piezoelectric current generated from the
ultrasonic power transmission activates spinal cord neural
circuits and enables paralyzed rats to move their hind legs.
Despite the fact that many technical challenges (such as
long-term reliability in usage, need for precise alignment
between the transceiver and the implant, integrated circuit
design for higher power conversion efficiency, etc.) are yet
to be addressed for the development of robust ultrasonicpowered stimulation micro-systems, we optimistically
consider the technique as a promising new avenue for
neuromodulation in the field of bioelectronic medicine.

Commentary
The concept of the piezoelectric stimulators has been
extensively studied (Piech et al. 2020; Phillips et al. 2003;
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Marino et al. 2017; Alam et al. 2019), but their efficacy
has not been established in comparison with conventional ES in terms of the restoration of involuntary
locomotion. The work by Li et al. provides further
insights to fill in the gap and demonstrate that piezoelectric
stimulation (pES) without a battery can achieve comparable
efficacy to ES. In this commentary, we discuss the article
details with emphasis on the technical aspects of implementing such systems.
Alignment and position

To effectively deliver acoustic energy for the piezoelectric
stimulator, accurate alignment and positioning between
the ultrasound transducer and piezoelectric stimulator are
critical during nerve stimulation. Piezoelectric devices
convert mechanical displacement into electrical charge,
and because they are comprised of a regularly repeating
crystalline structure they are sensitive to the relative angle
of applied mechanical energy. Ultrasound energy is also
attenuated with distance with a factor of attenuation
which depends on the materials that it passes through. In
general this requires a greater amount of energy to be
generated at the source compared to what is received at
the implanted device. However, there are techniques such
as focusing which can be used concentrate the energy at
the implant location while applying lower ultrasound
energy density over a larger skin contact area.
Piezoelectric stimulator dimensions

One of the potential benefits of utilizing ultrasound to
power a piezoelectric implant is that it obviates the necessity for a battery within the implantable device. Given
that batteries occupy a large percentage of the volume of
implantable devices, this enables the design of devices
that are significantly smaller in size than those requiring
batteries. In the article by Li et al., the diameter of the
piezoelectric stimulator employed was 10 mm with a

Fig. 1 Working principle of the ultrasound-driven piezoelectric stimulator interfacing the spinal cord for the restoration of involuntary locomotion.
The ultrasound energy provided by the probe is converted to electrical energy for neural stimulation by the implanted device
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height of 4 mm (Alam et al. 2019) yielding a volume of
314 mm3. Compared to some commercial button cells
(5.8 mm in diameter and 1.6 mm), the size of the piezoelectric stimulator is still relatively large and could benefit from further shrinking so that there will be more
options to implant the device into anatomical pockets of
small animals. However, this should not be considered
an issue for the applicability of piezoelectric stimulators
since mm scale implants have already been demonstrated (a recent example had a volume of 1.7 mm3
(Piech et al. 2020)).
Ultrasound biosafety considerations

All radiation exposure presents intrinsic safety and
health risk considerations due to the potential for tissue
damage. However, ultrasonic power transfer is widely
used in diagnostic imaging, and its risks are managed by
limiting the transmitted acoustic power density to a safe
amount. The maximum FDA limit on ultrasound exposure is 720 mW/cm2 spatial-peak temporal-average intensity (ISPTA) and 190 W/cm2 spatial-peak pulse-average
intensity (ISPPA) (Marketing Clearance of Diagnostic
Ultrasound Systems and Transducers 2019).
The transducer used by Li et al. outputs a maximum
of 22.5 mW/cm2 (ISPTA) at 40 Hz and 3.9 W/cm2 (ISPPA),
significantly below FDA limits. Although safe exposure
limits for rodents are not generally well established,
histological analysis from previous work suggests no
negative effects at this level of exposure (Kim et al.
2014). The size of the piezoelectric component plays a
role in the amount of power that can be effectively
transferred. The power transfer efficiency of the piezoelectric stimulator in this work was approximately
0.22%, from the input power to the driving transducer to
received electrical power at the stimulator. The significantly smaller design employed in (Piech et al. 2020) had
similar efficiencies of .33% in ex vivo tissue and .7% in a
gel phantom. However, the smaller design required
substantially higher amounts of ultrasound power to be
generated. This work showed that intensities as low as
0.1 mW/cm2 could induce motor evoked potentials and
that an intensity of 22.5 mW/cm2 could be used to induce locomotion in hind limbs. The smaller design in
(Piech et al. 2020) required a minimum intensity of 56
mW/cm2 at optimal orientation, alignment, distance;
and required 451 mW/cm2 at a distance of 55 mm
within ex vivo tissue. It should be noted that the FDA
limit for diagnostic ultrasound exposure of 720 mW/cm2
as stated above is only for peripheral vessels, and the
limits range down to 17 mW/cm2 for ophthalmic tissue.
This indicates that although it is possible to significantly
shrink such devices, there exists a tradeoff between
device size and the amount of power that can safely be
transferred to the device using ultrasound. Translation
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to clinical applications would require additional considerations, as limits differ for other organs in the body and
by operating frequency. Additionally, threshold intensity
will depend on acoustic impedance of surrounding tissue
and acoustic mismatch of tissue interfaces, which may
differ in clinical applications.
Encapsulation strategies

In their work, Li et al., encapsulated the piezoelectric
stimulator using a biocompatible silicone coating. The
lifetime and long-term reliability of the electrically
packaged stimulator remains unknown in the in vivo
environment and requires further longitudinal studies.
To reduce the fibrous tissue encapsulation surrounding
the piezoelectric stimulator and the resulting increase in
acoustic impedance, packaging techniques utilizing clinically proven long-lasting biocompatible materials need
to be developed and validated. Other approaches have
used a conformal coating of Parylene to encapsulate the
device (Piech et al. 2020), which according to the
authors was expected to last for durations of months to
years. Although Parylene is known to be biocompatible
and appealing because it can be deposited in very thin
layers, its longevity in biological environments remains
poor ever since it was first evaluated in the 1970s
(Barrese et al. 2013; Schmidt et al. 1988; Loeb et al.
1977). The degradation of Parylene encapsulated structures is primarily due to poor chemical bonding to
underlying substrates (Stieglitz et al. 2002) and moisture
absorption which lead to delamination and cracking over
time. These issues are further exacerbated when the
Parylene is selectively removed to expose active sites
such as electrodes which must contact the tissue, as this
results in an exposed interfacial surface underneath the
Parylene which presents an opportunity for moisture
ingress. Silicone encapsulation is appealing because it is
compliant and can be used to minimize the foreign body
response to the implant, however it suffers from similar
issues as Parylene including moisture absorption and
poor adhesion to underlying materials such as insulated
wires leading to electrodes. Another approach to
polymer-based packaging has been to incorporate layers
of different polymers such as Parylene and epoxy
(Wright et al. 2019) to try to benefit from the different
properties of the different materials, but the addition of
additional encapsulation layers and the resulting added
thickness can result in higher acoustical impedance and
lower power transfer efficiency for ultrasound powered
devices.
Comparison with conventional electrical stimulation

The efficacy of pES was rarely reported in systematic
comparison with ES. In this study, the efficacy of the
piezoelectric stimulator was validated by comparing
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motor evoked potentials in the hindlimb muscles
triggered by both epidural electrical stimulation and
piezoelectric stimulation. As evidenced by similar
recruitment of tibialis anterior muscles for ES and pES,
the efficacy of pES is comparable to conventional ES.
Likewise, both ES and pES rendered rats with SCI to
regain the hindlimb locomotion on a moving treadmill
belt, indicating that the performance of ES and pES is
likely to be consistent. However, this exploratory study
utilized seven rats; data generated from one rat was displayed in two figures (Figures 2d and 4 in the article),
but no formal hypothesis test was employed with statistical analysis. Additional data and a more comprehensive
statistical analysis are needed to conduct an efficacy
comparison between ES and pES.
While this article focuses on the effects of pES, ultrasound exposure can also stimulate neuronal circuits, and its
effects have been established in studies spanning multiple
species at varying frequencies and intensity levels (Tufail
et al. 2011). In (Cotero et al. 2019) it was shown that
ultrasound pressures well within the limits for diagnostic
imaging were successfully able to stimulate substructures
within organs resulting in changes in production of inflammatory markers in a manner similar to stimulating the
vagus nerve (Pavlov and Tracey 2012). Further studies are
required to understand the possibility of transferring
ultrasound energy to implants in a manner which does not
disturb normal operation of the biological systems in the
body. Importantly, pES should be compared to sham stimulation (in which the same transducer setup is used in
conjunction with a “dummy” implant) to isolate the effects
of pES from the effects of ultrasound exposure.
Wireless stimulation

Neural stimulation systems are either wireless or wired.
Both type of systems require an implanted electrode to
interface to the nervous system. Wired systems require
physical wired connections from the implanted device to
an external benchtop system providing either stimulation
pulses or power for electronics within the device. Wireless
systems incorporate stimulation generation within the
implanted device and can be powered using either internal
energy storage such as a battery or capacitor, or by
wirelessly receiving power from an external power source.
Wired systems require handling of the animal to attach
the wires, and once attached, they limit the movement of
the animal, leading to trauma and restriction of the
animal’s normal behavior. Additionally, the percutaneous
connectors used for wired systems present a lasting
opportunity for infection and irritation to the animal.
Truly wireless systems do not have these issues since they
can be controlled and powered wirelessly.
Ultrasound-based powering of implantable devices is
generally considered to be part of a wireless system, but
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may not provide all of the benefits of wireless implants
outside of the lack of a percutaneous connection system.
Ultrasound power is significantly attenuated in air, and
proper power transfer for the types of systems described
here requires intimate contact between the ultrasound
transducer and the skin. This additionally requires
restraining and possibly anesthetizing the animal, which
can be a source of trauma and change the physiological
state of the animal. This appears to be a fundamental
limit of ultrasound powered systems; to our knowledge
there is no ultrasound powered implant which does not
require intimate contact between the power source and
the animal.

Conclusion
This research shows promising results to restore involuntary locomotion for rats with SCI, using a novel piezoelectric stimulator. The authors compared the motor evoked
potentials in the hind limb muscles response to epidural
electrical stimulation and piezoelectric stimulation, and restored the hind limb locomotion for rats with SCI by these
two approaches. Eventually, this study demonstrated that
there was no notable difference between epidural electrical
stimulation and piezoelectric stimulation in terms of motor
evoked potentials and involuntary locomotion restoration,
laying a solid foundation to prove the value for pES.
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